| Dr Stephen B Lillard, DO | |
|
1000 E Cherry St, Attn: 3rd Floor Pulmonary Clinic, Troy, MO 63379-1513 | |
| (636) 528-3321 | |
| (636) 528-3212 |
| Full Name | Dr Stephen B Lillard |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine - Pulmonary Disease |
| Location | 1000 E Cherry St, Troy, Missouri |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1285625749 | NPI | - | NPPES |
| 1285625749 | Medicaid | WI | |
| CE7661 | Other | MEDICARE RAILROAD | |
| 241895705 | Medicaid | MO | |
| P00060884 | Other | MEDICARE RR INDIV |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RP1001X | Internal Medicine - Pulmonary Disease | 80126-21 (Wisconsin) | Secondary |
| 207RP1001X | Internal Medicine - Pulmonary Disease | MO32884 (Missouri) | Primary |
| Entity Name | Missouri Delta Medical Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1508967860 PECOS PAC ID: 1355252891 Enrollment ID: O20040308001306 |
News Archive
As the world struggles to contain COVID-19, a group of leading, scientific experts from the U.S., Latin America, Africa, and South Asia released a report today outlining the strong scientific foundations for taking actions to stop the next pandemic by preventing the spillover of pathogens from animals to people.
PerkinElmer, Inc., a global leader focused on the health and safety of people and the environment, today announced the introduction of a wide range of new tools to improve the speed and effectiveness of life sciences research.
GW Pharmaceuticals plc, a biopharmaceutical company focused on discovering, developing and commercializing novel therapeutics from its proprietary cannabinoid product platform, announced that it has submitted an application under the European Mutual Recognition Procedure seeking to expand the marketing authorization for Sativex into France for the treatment of spasticity due to Multiple Sclerosis.
Merck, known as MSD outside the United States and Canada, today announced results of new exploratory pre-specified analyses from the ongoing STARTMRK Phase III study of its integrase inhibitor ISENTRESS (raltegravir) Tablets in combination therapy compared to efavirenz in combination therapy in previously untreated adult HIV-1-infected patients.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Stephen B Lillard, DO 1000 E Cherry St, Attn: 3rd Floor Pulmonary Clinic, Troy, MO 63379-1513 Ph: (636) 528-3321 | Dr Stephen B Lillard, DO 1000 E Cherry St, Attn: 3rd Floor Pulmonary Clinic, Troy, MO 63379-1513 Ph: (636) 528-3321 |
News Archive
As the world struggles to contain COVID-19, a group of leading, scientific experts from the U.S., Latin America, Africa, and South Asia released a report today outlining the strong scientific foundations for taking actions to stop the next pandemic by preventing the spillover of pathogens from animals to people.
PerkinElmer, Inc., a global leader focused on the health and safety of people and the environment, today announced the introduction of a wide range of new tools to improve the speed and effectiveness of life sciences research.
GW Pharmaceuticals plc, a biopharmaceutical company focused on discovering, developing and commercializing novel therapeutics from its proprietary cannabinoid product platform, announced that it has submitted an application under the European Mutual Recognition Procedure seeking to expand the marketing authorization for Sativex into France for the treatment of spasticity due to Multiple Sclerosis.
Merck, known as MSD outside the United States and Canada, today announced results of new exploratory pre-specified analyses from the ongoing STARTMRK Phase III study of its integrase inhibitor ISENTRESS (raltegravir) Tablets in combination therapy compared to efavirenz in combination therapy in previously untreated adult HIV-1-infected patients.
› Verified 7 days ago
Dr. James Lee Bockhorst, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 1177 E Cherry St, Troy, MO 63379 Phone: 636-528-1919 Fax: 636-528-1916 | |
Zoey Levine, Pulmonary Disease Medicare: Medicare Enrolled Practice Location: 9 Lincoln Ctr, Troy, MO 63379 Phone: 636-720-0310 Fax: 636-720-0311 | |
Dr. Rodrigo G Goh, M.D. Pulmonary Disease Medicare: Not Enrolled in Medicare Practice Location: 172 Professional Parkway, Po Box A, Troy, MO 63379 Phone: 636-462-6106 Fax: 636-669-2401 | |
Scott Alan Barton, D.O. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 1000 E Cherry St, Troy, MO 63379 Phone: 636-528-3245 |